Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas

Purpose To develop a Radiation Therapy Oncology Group (RTOG) atlas of the elective clinical target volume (CTV) definitions to be used for planning pelvic intensity-modulated radiotherapy (IMRT) for anal and rectal cancers.

[1]  D. Dearnaley,et al.  Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. , 2006, International journal of radiation oncology, biology, physics.

[2]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[3]  J. Fleiss.  Statistical methods for rates and proportions , 1974 .

[4]  R. Drzymala,et al.  Technical aspects of image-based treatment planning of rectal carcinoma. , 2003, Seminars in radiation oncology.

[5]  D. Yan,et al.  The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. , 2002, International journal of radiation oncology, biology, physics.

[6]  Robert C. Frazier,et al.  The dose-volume realationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer , 2002 .

[7]  S. Lipsitz,et al.  Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. , 1996, International journal of radiation oncology, biology, physics.

[8]  Peter Smeets,et al.  Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. , 2004, International journal of radiation oncology, biology, physics.

[9]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[10]  N. Petrelli,et al.  Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Risk of pelvic fractures in older women following pelvic irradiation , 2005 .

[12]  P. Parikh,et al.  RTOG 0529: A Phase II Evaluation of Dose-painted IMRT in Combination with 5-Fluorouracil and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal , 2009 .

[13]  C. Willett,et al.  Randomized phase II trial of preoperative combined modality chemoradiation for distal rectal cancer , 2004 .

[14]  Tae Hyun Kim,et al.  Intensity-modulated radiotherapy with a belly board for rectal cancer , 2007, International Journal of Colorectal Disease.

[15]  Yi-Jen Chen,et al.  Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. , 2005, International journal of radiation oncology, biology, physics.

[16]  Bernard Leduc,et al.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Yan,et al.  The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer. , 2004, Cancer Radiothérapie.

[18]  Ashesh B Jani,et al.  Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. , 2005, International journal of radiation oncology, biology, physics.

[19]  Karin Haustermans,et al.  Definition and delineation of the clinical target volume for rectal cancer. , 2006, International journal of radiation oncology, biology, physics.

[20]  M M Kligerman,et al.  A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. , 1986, International journal of radiation oncology, biology, physics.

[21]  J. Roeske,et al.  Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  William M. Wells,et al.  Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation , 2004, IEEE Transactions on Medical Imaging.

[23]  L. Tho,et al.  Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. , 2006, International journal of radiation oncology, biology, physics.

[24]  Laurence Collette,et al.  Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.

[25]  A. Markoe,et al.  Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. , 1996, The cancer journal from Scientific American.

[26]  P. Bendahl,et al.  Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer , 2007, Acta oncologica.

[27]  Charles R. Thomas,et al.  43 : Intergroup RTOG 9811 Phase III Comparison Of Chemoradiation With 5-FU and Mitomycin Vs 5-FU and Cisplatin for Anal Canal Carcinoma: Impact on Disease-Free, Overall and Colostomy-Free Survival , 2006 .

[28]  C. Lemanski,et al.  Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans , 2007, Radiation oncology.

[29]  E. Sigurdson,et al.  Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. , 2007, International journal of radiation oncology, biology, physics.